AVESTHAGEN LIMITED
BRINGING SCIENCE TO LIFE - Convergence of Food Pharma & Population Genetics
109 employees · est. 2001 · India
RareCan
RareCan aims to accelerate research and ultimately improve treatments and outcomes for people with rare cancers.
8 employees · est. 2019 · United Kingdom
AVESTHAGEN LIMITED is the older company (2001 vs 2019); AVESTHAGEN LIMITED is the larger of the two.
Side-by-Side Comparison
| Metric | AVESTHAGEN LIMITED | RareCan |
|---|---|---|
| Founded | ||
| Founded | 2001 older | 2019 |
| Headquarters | ||
| Headquarters | India | United Kingdom |
| Employees | ||
| Employees | 109 larger | 8 |
| Industry | ||
| Industry | Biotechnology, Health Care, Pharmaceutical | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Series Unknown | Equity Crowdfunding |
| Total Funding | ||
| Total Funding | $5.53M | $576.88K |
| Funding Rounds | ||
| Funding Rounds | 1 | 3 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Systems Biology, Life Science, Biobank, Population Genetics, Epidemiological Study, Precision Medicine, Cancer Research, NGS (Next-Generation Sequencing), Bioinformatics, Healthcare Innovation, Environmental Sustainability, Personalized Medicine, Data-driven Research | Rare Cancers, Clinical Trials, Patient Recruitment, Research Acceleration, Bio-samples, Genetic Data, NHS Trusts, Patient Organizations, Cancer Research, Data Access, Treatment Outcomes, Precision Cohort, Histology-independent Trials, Life Sciences Companies, Global Research Network |
| Website | ||
| Website | avesthagen.com | rarecan.com |
About AVESTHAGEN LIMITED
Avesthagen Limited, with the slogan "BRINGING SCIENCE TO LIFE - Convergence of Food Pharma & Population Genetics," is a leading systems biology life science company that aims to address global healthcare and environmental challenges. Founded in 1998, the company has focused on introducing new ideas,...
About RareCan
RareCan is a United Kingdom-based biotechnology and healthcare company, founded in 2019, with a mission to accelerate research and improve treatments for individuals with rare cancers. The company has recently secured a £374.88K Equity Crowdfunding investment on 15 June 2022 through Crowdcube. Rare...
We will tell you when either one moves
BounceWatch watches AVESTHAGEN LIMITED and RareCan for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at AVESTHAGEN LIMITED and RareCan — by email.
Frequently Asked Questions
Compare AVESTHAGEN LIMITED with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at AVESTHAGEN LIMITED on 12 Sep 2024, and RareCan on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
